| Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de … D Blaise, M Kuentz, C Fortanier, JH Bourhis, N Milpied, L Sutton, JP Jouet, ... Journal of Clinical Oncology 18 (3), 537-537, 2000 | 452 | 2000 |
| Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach B Spire, S Duran, M Souville, C Leport, F Raffi, JP Moatti Social science & medicine 54 (10), 1481-1496, 2002 | 449 | 2002 |
| Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy S Duran, M Savès, B Spire, V Cailleton, A Sobel, P Carrieri, D Salmon, ... Aids 15 (18), 2441-2444, 2001 | 355 | 2001 |
| Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment JP Moatti, MP Carrieri, B Spire, JA Gastaut, JP Cassuto, J Moreau, ... Aids 14 (2), 151-155, 2000 | 313 | 2000 |
| Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance? M Schwarzinger, R Flicoteaux, S Cortarenoda, Y Obadia, JP Moatti PloS one 5 (4), e10199, 2010 | 310 | 2010 |
| Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART S Duran, B Spire, F Raffi, V Walter, D Bouhour, V Journot, V Cailleton, ... HIV clinical trials 2 (1), 38-45, 2001 | 310 | 2001 |
| Global sustainable development report 2019: the future is now–science for achieving sustainable development P Messerli, E Murniningtyas, P Eloundou-Enyegue, EG Foli, E Furman, ... United Nations, 2019 | 286 | 2019 |
| The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort P Carrieri, V Cailleton, V Le Moing, B Spire, P Dellamonica, E Bouvet, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 28 (3), 232-239, 2001 | 244 | 2001 |
| Le principe de prévention: le culte de la santé et ses dérives P Peretti-Watel, JP Moatti (No Title), 2009 | 227 | 2009 |
| Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy MANIF 2000 Study Group Antiviral Therapy 10 (1), 53-61, 2005 | 218 | 2005 |
| Injecting misuse of buprenorphine among French drug users Y Obadia, V Perrin, I Feroni, D Vlahov, JP Moatti Addiction 96 (2), 267-272, 2001 | 214 | 2001 |
| Health-related quality of life after 1 year of highly active antiretroviral therapy P Carrieri, B Spire, S Duran, C Katlama, D Peyramond, C François, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 32 (1), 38-47, 2003 | 193 | 2003 |
| Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen V Le Moing, G Chêne, MP Carrieri, A Alioum, F Brun-Vézinet, L Piroth, ... Aids 16 (1), 21-29, 2002 | 193 | 2002 |
| Nonadherence among HIV-infected injecting drug users: the impact of social instability AD Bouhnik, M Chesney, P Carrieri, H Gallais, J Moreau, JP Moatti, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S149-S153, 2002 | 188 | 2002 |
| Risk perception and social acceptability of technologies: The French case S Bastide, JP Moatti, JP Pages, F Fagnani Risk analysis 9 (2), 215-223, 1989 | 171 | 1989 |
| Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study P Christian, B Laurence, S Bruno, TT Catherine, M Michel, S Marc, ... HIV Clinical Trials 4 (2), 121-131, 2003 | 166 | 2003 |
| Determinants of patients’ choice of reconstruction with mastectomy for primary breast cancer P Ananian, G Houvenaeghel, C Protiere, P Rouanet, S Arnaud, JP Moatti, ... Annals of Surgical Oncology 11, 762-771, 2004 | 155 | 2004 |
| Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment … MP Carrieri, C Leport, C Protopopescu, JP Cassuto, E Bouvet, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (4), 477-485, 2006 | 148 | 2006 |
| Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study MP Carrieri, F Raffi, C Lewden, A Sobel, C Michelet, V Cailleton, G Chêne, ... Antiviral therapy 8 (6), 585-594, 2003 | 148 | 2003 |
| Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users MP Carrieri, MA Chesney, B Spire, A Loundou, A Sobel, G Lepeu, ... International journal of behavioral medicine 10, 1-14, 2003 | 146 | 2003 |
